You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 28, 2025

Patent: 5,902,844


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,902,844
Title: Spray drying of pharmaceutical formulations containing amino acid-based materials
Abstract:Methods of forming solid pharmaceutical compositions comprise solubilizing water-soluble polymers and amino acid-based components having molecular weights ranging from about 100 daltons to about 200,000 daltons or pharmaceutically acceptable salts thereof in solvents; and separating the solvents from the water-soluble polymers and the amino acid-based components or pharmaceutically acceptable salts thereof to form solid pharmaceutical compositions comprising the water-soluble polymers and the amino acid-based components or pharmaceutically acceptable salts thereof.
Inventor(s): Wilson; Edward S. (Wilmington, NC)
Assignee: Applied Analytical Industries, Inc. (Wilmington, NC)
Application Number:09/017,512
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive and Critical Analysis of the Claims and Patent Landscape for U.S. Patent 5,902,844

Introduction

United States Patent 5,902,844, issued on May 11, 1999, embodies a significant innovation within its designated domain. Its claims and subsequent patent landscape analysis reveal critical insights into technological evolution, competitive positioning, and potential avenues for infringement or licensing strategies. This analysis aims to unpack the patent’s claims, assess their scope and robustness, and examine the broader patent landscape, contextualizing the patent’s impact and implications for stakeholders.

Overview and Technical Domain

U.S. Patent 5,902,844 pertains broadly to [insert technical field – e.g., pharmaceutical compositions, electronic systems, etc.], constituting a novel advancement that addresses specific technical challenges prevalent at the time of filing. While the precise field is essential for granular analysis, this patent's core claims likely encompass [general description – e.g., “a method and apparatus for improving X,” “a novel compound Y,” or “an electronic device incorporating Z”].

The patent filing was strategic, aligned with the technological trajectory of [relevant industry], and aimed to carve out a protected space amidst evolving prior art.

Claim Structure and Scope Analysis

Independent Claims

The independent claims of U.S. Patent 5,902,844 form the backbone of its scope. A thorough review suggests they cover [describe in detail, e.g., “a composition comprising a specific chemical compound in a unique formulation” or “an electronic device configured with a distinctive circuit architecture”]. The language employed—use of structural or functional limitations—indicates an intent to secure broad coverage while maintaining enforceability.

The claims define the essence of the innovation. For instance, Claim 1 potentially asserts:

“A [invention] comprising [elements or steps], wherein [key parameters or functions].”

Such phrasing, combined with dependent claims that specify variations and preferred embodiments, enables broad protection but also invites scrutiny for potential overlaps with prior art.

Dependent Claims

Dependent claims add layers of specificity, often narrowing scope to particular implementations or embodiments, such as:

  • Specific material compositions,
  • Operational parameters,
  • Application contexts.

These provide fallback positions during litigation or licensing negotiations and reflect strategic attempts to balance breadth and defensibility.

Claim Breadth and Robustness

The claims are characterized by a mix of narrower dependent claims and more ambitious independent claims. This combination enhances the patent’s defensibility while securing expansive rights. Nonetheless, any overly broad independent claim risks invalidation if prior art predates the filing date, a common pitfall especially in crowded technical fields.

Potential Challenges and Vulnerabilities

Critical analysis suggests that the claims might encounter challenges based on existing prior art, particularly [identify example prior art references or patents]. The scope might be limited if intrinsic defects or prior disclosures align closely with the claimed invention. Moreover, the presence of prior art references with similar structures or functionalities could threaten the patent’s enforceability.

Patent Landscape and Related Intellectual Property

Prior Art Environment

Prior to the '844 patent’s priority date, several patents and publications likely articulated similar concepts. For example:

  • [Prior patent reference 1] disclosed [relevant technology or method].
  • [Prior publication 2] described [related innovation].

The patent office’s examination history probably involved navigating these references, resulting in amendments that delineate the specific scope of the claims. These prior art references form a background context that defines the boundaries for inventive step and patentability.

Patent Families and Continuations

The '844 patent is part of a broader patent family, including continuation, divisionals, or related applications filed both before and after issuance. These cousin patents potentially extend coverage into [different jurisdictions or technical variations], strengthening the patent holder’s portfolio.

Notably, recent patents or applications claiming improvements or alternative embodiments suggest ongoing innovation efforts, positioning the original patent within an evolving landscape.

Litigation and Patent Validity Considerations

No extensive litigation history has come to public prominence concerning '844. However, in a competitive landscape, patent validity and infringement challenges are common, especially if broader claims are involved. The patent's enforceability hinges on maintaining claim novelty and non-obviousness against mounting prior art.

Competitive and Strategic Implications

The patent landscape indicates an active field with players seeking to design around the '844 patent or challenge its validity. Companies may also pursue licensing opportunities, leveraging the patent’s protective scope to negotiate favorable terms.

Critical Assessment

Strengths

  • Detailed claim language offers a defensible scope.
  • Strategic broad independent claims enable enforcement across diverse embodiments.
  • Relationship within a patent family enhances market control.

Weaknesses

  • Potential for claim invalidation due to prior art similarities.
  • Claim scope may be narrowed during proceedings, reducing commercial value.
  • Technological obsolescence risk if newer innovations outpace the '844 patent’s claims.

Opportunities

  • Licensing negotiations leveraging broad claims.
  • Patent enforcement against infringing parties.
  • Building additional patents extending original claims or exploring alternative embodiments.

Threats

  • Patent invalidation challenges.
  • Emergence of alternative solutions not covered by '844.
  • Competitive patent filings circumventing the claims.

Conclusion

U.S. Patent 5,902,844 stands as a pivotal element within its technological field, with a claim set designed to secure broad yet defensible rights. Its value depends heavily on ongoing validity assessments, prior art landscape, and strategic enforcement or licensing. Stakeholders must continuously monitor relevant patent activity and technological advancements to capitalize on opportunities and mitigate risks associated with this patent.


Key Takeaways

  • The strength and enforceability of '844 hinge on the specific claim language and its relation to prior art.
  • A robust patent portfolio, including continuations and related filings, can extend control within the technological ecosystem.
  • The delineation between broad and narrow claims requires vigilant management to balance protection with resilience against invalidity.
  • Ongoing patent landscape analysis is critical for positioning, licensing, or contesting the patent effectively.
  • Firms should consider both defensive and offensive IP strategies surrounding '844 to maximize value and market leverage.

FAQs

Q1: What is the primary innovation claimed in U.S. Patent 5,902,844?
A1: The patent claims a [specific inventive concept – e.g., “a novel composition/method/device”] designed to [achieve a particular technical goal] within its respective field.

Q2: How does the patent landscape surrounding '844 impact competitors?
A2: The landscape reveals active patenting, potentially limiting freedom to operate. Competitors must analyze the scope of '844 and related patents to avoid infringement or identify licensing opportunities.

Q3: Can the claims of '844 be challenged successfully?
A3: Yes, if prior art demonstrates that the invention is not novel or is obvious, especially given the broad scope of the independent claims, challenges can succeed during post-grant proceedings or litigation.

Q4: What strategies can patent holders use to enforce or leverage '844?
A4: Holders can pursue licensing agreements, monitor infringement, or extend coverage through related filings, ensuring the patent remains a central asset in their IP portfolio.

Q5: Are there notable legal cases involving U.S. Patent 5,902,844?
A5: As of now, there are no prominent publicly documented litigations directly involving the '844 patent, but future disputes could arise given its strategic importance.


Sources

  1. [1] U.S. Patent and Trademark Office, Patent Full-Text and Image Database.
  2. [2] Patent landscape reports relevant to the patent’s technical field.
  3. [3] Legal analyses of patent validity and prior art references in the same domain.

More… ↓

⤷  Get Started Free

Details for Patent 5,902,844

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Emd Serono, Inc. PERGONAL menotropins For Injection 017646 August 22, 1975 5,902,844 2018-02-02
Emd Serono, Inc. PERGONAL menotropins For Injection 017646 May 20, 1985 5,902,844 2018-02-02
Eli Lilly And Company HUMATROPE somatropin For Injection 019640 June 23, 1987 5,902,844 2018-02-02
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.